Changchun GeneScience Pharmaceutical Co.,Ltd.

Commercialized in China since 2014
Administration once a week

Commercialized for more than 20 years

We can manufacture high quality activated PEG products with high purity in cGMP grade. Our reactive polyethylene glycol derivatives and raw materials can be utilized widely in the pharmaceutical, biotechnology and emerging chemical specialty fields.

Customized PEG synthesis service is available:...

For more information, please contact us at [email protected]

12.5IU precise adjustment.
Available in three injection strengths(300/450/600IU).

Recently, the National Medical Products Administration (NMPA) of China announced that Gensci's Class 1 innovative drug Jin Beixin Firsekibart has received approval. This drug is indicated for gouty arthritis (GA) treatment in adult patients for whom NSAIDs and/or colchicine are contraindicated, not tolerated, or ineffective and for whom repeated courses of corticosteroids are not suitable. Leveraging its clinical advantages of sustained symptom control, rapid onset of action and a favorable safety profile, Jin Beixin Firsekibart is expected to be China’s best-selling drug to address the unmet need in the treatment of autoimmune diseases. 

GenSci's Product List